Ftse Mib
37.675,40
-1,44%
DAX
22.328,77
-1,23%
S&P 500
5.572,07
-0,76%
NASDAQ
17.436,10
-0,18%
Bitcoin
83.071,73
5,86%
Pepperstone
Advertisement
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Apogee Therapeutics Inc (APGE) Apogee Therapeutics Inc (APGE) Notizie

Apogee Therapeutics Inc

APGE
40,27
2,73 (7,27%)
Dopo l'orario di negoziazione
Ultimo aggiornamento: 21:54:53
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
11/3/202511:30EDGAR2Form 8-K - Current report
08/3/202502:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/3/202513:12EDGAR2Form 8-K - Current report
03/3/202513:06EDGAR2Form S-8 - Securities to be offered to employees in employee..
03/3/202512:30EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
03/3/202512:05GLOBEApogee Therapeutics Provides Pipeline Progress and Reports..
03/3/202512:00GLOBEApogee Therapeutics Announces Positive Interim Phase 1..
28/2/202522:00GLOBEApogee Therapeutics to Host Conference Call to Report..
25/2/202513:30GLOBEApogee Therapeutics to Participate in Upcoming March..
08/2/202502:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/2/202513:05EDGAR2Form 8-K - Current report
03/2/202513:00GLOBEApogee Therapeutics Announces First Patient Dosed in Part B..
29/1/202513:30GLOBEApogee Therapeutics to Participate at the Guggenheim SMID..
04/1/202502:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/12/202402:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/12/202402:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/12/202422:59EDGAR2Form 144 - Report of proposed sale of securities
10/12/202413:30EDGAR2Form 8-K - Current report
10/12/202413:00GLOBEApogee Therapeutics Announces First Participants Dosed in..
07/12/202402:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/12/202412:17EDGAR2Form 8-K - Current report
02/12/202412:00GLOBEApogee Therapeutics Highlights Progress and Best-in-Class..
29/11/202419:00GLOBEApogee Therapeutics Announces Agenda for Virtual R&D Day
18/11/202413:30GLOBEApogee Therapeutics to Host Inaugural Virtual R&D Day on..
12/11/202413:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
12/11/202413:05EDGAR2Form 8-K - Current report
12/11/202413:00GLOBEApogee Therapeutics Provides Pipeline Progress and Reports..
09/11/202402:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/11/202420:17EDGAR2Form SC 13G - Statement of Beneficial Ownership by Certain..
04/11/202413:30GLOBEApogee Therapeutics to Participate in Upcoming November..
24/10/202414:10EDGAR2Form 8-K - Current report
24/10/202414:00GLOBEApogee Therapeutics Announces Results Up to 9 Months from..
16/10/202413:00GLOBEApogee Therapeutics Announces Poster Presentation at the..
05/10/202402:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/10/202422:20EDGAR2Form 144 - Report of proposed sale of securities
12/9/202413:00GLOBEApogee Therapeutics to Participate at the Stifel 2024..
09/9/202413:00GLOBEApogee Therapeutics Appoints Jeff S. Hartness as Chief..
07/9/202402:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/8/202413:29EDGAR2Form 8-K - Current report
19/8/202413:00GLOBEApogee Therapeutics Announces First Participants Dosed in..
12/8/202423:25EDGAR2Form S-3ASR - Automatic shelf registration statement of..
12/8/202422:05EDGAR2Form S-8 - Securities to be offered to employees in employee..
12/8/202413:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
12/8/202412:35EDGAR2Form 8-K - Current report
12/8/202412:30GLOBEApogee Therapeutics Provides Pipeline Progress and Reports..
10/8/202402:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/7/202414:00GLOBENewAmsterdam Pharma Announces Appointments of Mark C...
06/7/202402:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/6/202402:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/6/202422:02EDGAR2Form 8-K - Current report
Apertura: 37,54 Min: 35,935 Max: 41,255
Chiusura: 37,54

La tua Cronologia

NASDAQ
APGE
Apogee Therapeutics
BOV
DIRR3T
DIRECIONAL
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci